Literature DB >> 19056782

Factor I and factor H deficiency in renal diseases: similar defects in the fluid phase have a different outcome at the surface of the glomerular basement membrane.

Peter F Zipfel1, Richard J H Smith, Christine Skerka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19056782      PMCID： PMC2727304          DOI： 10.1093/ndt/gfn652

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  12 in total

1.  Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF).

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

2.  Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up.

Authors:  R Schwertz; U Rother; D Anders; N Gretz; K Schärer; M Kirschfink
Journal:  Pediatr Allergy Immunol       Date:  2001-06       Impact factor: 6.377

Review 3.  Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.

Authors:  Gerald B Appel; H Terence Cook; Gregory Hageman; J Charles Jennette; Michael Kashgarian; Michael Kirschfink; John D Lambris; Lynne Lanning; Hans U Lutz; Seppo Meri; Noel R Rose; David J Salant; Sanjeev Sethi; Richard J H Smith; William Smoyer; Hope F Tully; Sean P Tully; Patrick Walker; Michael Welsh; Reinhard Würzner; Peter F Zipfel
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

4.  The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.

Authors:  Rebecca E Saunders; Cynthia Abarrategui-Garrido; Véronique Frémeaux-Bacchi; Elena Goicoechea de Jorge; Timothy H J Goodship; Margarita López Trascasa; Marina Noris; Isabel Maria Ponce Castro; Giuseppe Remuzzi; Santiago Rodríguez de Córdoba; Pilar Sánchez-Corral; Christine Skerka; Peter F Zipfel; Stephen J Perkins
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

5.  Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.

Authors:  T S Jokiranta; A Solomon; M K Pangburn; P F Zipfel; S Meri
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

6.  Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).

Authors:  C Licht; S Heinen; M Józsi; I Löschmann; R E Saunders; S J Perkins; R Waldherr; C Skerka; M Kirschfink; B Hoppe; P F Zipfel
Journal:  Kidney Int       Date:  2006-04-12       Impact factor: 10.612

7.  Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.

Authors:  Matthew C Pickering; H Terence Cook; Joanna Warren; Anne E Bygrave; Jill Moss; Mark J Walport; Marina Botto
Journal:  Nat Genet       Date:  2002-07-01       Impact factor: 38.330

8.  Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.

Authors:  Olivia Boyer; Laure-Hélène Noël; Eve Balzamo; Geneviève Guest; Nathalie Biebuyck; Marina Charbit; Rémi Salomon; Véronique Frémeaux-Bacchi; Patrick Niaudet
Journal:  Am J Kidney Dis       Date:  2008-04       Impact factor: 8.860

Review 9.  New approaches to the treatment of dense deposit disease.

Authors:  Richard J H Smith; Jessy Alexander; Paul N Barlow; Marina Botto; Thomas L Cassavant; H Terence Cook; Santiago Rodriguez de Córdoba; Gregory S Hageman; T Sakari Jokiranta; William J Kimberling; John D Lambris; Lynne D Lanning; Vicki Levidiotis; Christoph Licht; Hans U Lutz; Seppo Meri; Matthew C Pickering; Richard J Quigg; Angelique L Rops; David J Salant; Sanjeev Sethi; Joshua M Thurman; Hope F Tully; Sean P Tully; Johan van der Vlag; Patrick D Walker; Reinhard Würzner; Peter F Zipfel
Journal:  J Am Soc Nephrol       Date:  2007-08-05       Impact factor: 10.121

10.  Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.

Authors:  Kirsten L Rose; Danielle Paixao-Cavalcante; Jennifer Fish; Anthony P Manderson; Talat H Malik; Anne E Bygrave; Tao Lin; Steven H Sacks; Mark J Walport; H Terence Cook; Marina Botto; Matthew C Pickering
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808
View more
  5 in total

1.  Circulating complement levels and C3 glomerulopathy.

Authors:  Fernando C Fervenza; Sanjeev Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-23       Impact factor: 8.237

2.  Pathogenic Rickettsia species acquire vitronectin from human serum to promote resistance to complement-mediated killing.

Authors:  Sean P Riley; Jennifer L Patterson; Samantha Nava; Juan J Martinez
Journal:  Cell Microbiol       Date:  2013-12-13       Impact factor: 3.715

3.  Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.

Authors:  Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard J Smith; Richard R Kew
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

Review 4.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

5.  Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives: a case report.

Authors:  Thomas Idorn; Lone Schejbel; Casper Rydahl; James Goya Heaf; Karen Riis Jølvig; Marie Bergstrøm; Peter Garred; Anne-Lise Kamper
Journal:  BMC Nephrol       Date:  2012-07-26       Impact factor: 2.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.